Companion Animals

Dog Malignant Melanoma and Immunotherapy Welfare

Canine oral and digital malignant melanoma carries a poor prognosis but has responded to immunotherapy including a conditionally licensed DNA vaccine, offering welfare-extending options.

Key Facts

Welfare Considerations

Malignant melanoma welfare decisions require honest prognosis conversations at every stage. Oral melanomas carry high metastatic risk regardless of local control, meaning extensive surgery to achieve clean margins may provide months of local disease control without preventing systemic spread. The melanoma vaccine extends median survival and offers a welfare-positive adjuvant option with minimal side effects. However, the progression to metastatic disease requires ongoing quality of life monitoring and willingness to transition to palliative care when treatment burden outweighs benefit.

What You Can Do